Kenneth Hillan Insider Trading $SGMO SANGAMO THERAPEUTICS, INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Kenneth Hillan.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Kenneth Hillan. Kenneth Hillan is Director in SANGAMO THERAPEUTICS, INC ($SGMO) and Chief Executive Officer in Achaogen Inc ($AKAO) and See Remarks in Achaogen Inc ($AKAO) and Director in Zymeworks Inc. ($ZYME) and Director in Relypsa Inc ($RLYP).

Kenneth Hillan in SANGAMO THERAPEUTICS, INC

Trading Symbol: SGMO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Kenneth Hillan: Director
Holdings: 23,200 shares
Current Value: $89,320
Latest Transaction: Mar 01 2021
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Kenneth Hillan in SANGAMO THERAPEUTICS, INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AKAO, RLYP, SGMO, ZYME

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 01 2021	SGMO	SANGAMO THERAPEUTI ...	Hillan Kenneth J.	Director	Option Exercise	A	11.19	16,400	183,516	16,400
Mar 01 2021	SGMO	SANGAMO THERAPEUTI ...	Hillan Kenneth J.	Director	Grant	A	0.00	8,200	0	23,200	15 K to 23.2 K (+54.67 %)
Sep 11 2020	SGMO	SANGAMO THERAPEUTI ...	Hillan Kenneth J.	Director	Option Exercise	A	10.43	30,000	312,900	30,000
Sep 11 2020	SGMO	SANGAMO THERAPEUTI ...	Hillan Kenneth J.	Director	Grant	A	0.00	15,000	0	15,000	0 to 15 K

Page: 1